V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300006886 | 300004958 | 1.72 | 93.2 | null | 2014-06-03 | 2014-06-03 | Gemcitabine + Capecitabine | 02 | null | 300024303 | CARBOPLATIN |
| 300006887 | 300004960 | null | 74.6 | Palliative (P) | 2015-07-04 | 2015-08-11 | Capecitabine | N | N | 300024335 | CAPECITABINE + OXALIPLATIN |
| 300006888 | 300007060 | 1.77 | 81.4 | null | 2014-02-05 | 2014-02-05 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | null | 300024337 | HYDROXYCARBAMIDE |
| 300006889 | 300004961 | 1.64 | 95 | Palliative (P) | null | 2014-10-22 | Cisplatin +Fluorouracil (2 wk) | N | N | 300024339 | CAPECITABINE + OXALIPLATIN |
| 300006890 | 300004961 | 1.66 | null | Palliative (P) | 2014-09-12 | 2014-11-26 | Oxaliplatin + Modified de Gramont | Y | null | 300024339 | OXALIPLATIN |
| 300006891 | 300004964 | 1.65 | null | Palliative (P) | 2017-06-30 | 2017-07-02 | GEMCITABINE + NAB PACLITAXEL | 02 | N | 300024361 | CAPECITABINE + MITOMYCIN |
| 300006892 | 300007063 | 1.78 | null | Curative (C) | 2015-07-08 | 2015-07-15 | Cetuximab + Radiotherapy Maint | N | Y | 300024382 | CETUXIMAB + RT |
| 300006893 | 300004966 | 1.77 | 88 | Curative (C) | 2016-06-30 | 2016-09-08 | Carboplatin AUC 2 - 5 | null | Y | 300024383 | CAPECITABINE + OXALIPLATIN |
| 300006894 | 300004967 | 1.73 | null | Palliative (P) | 2015-08-01 | 2015-09-10 | Oxaliplatin + Modified de Gramont | 02 | N | 300024391 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006895 | 300004968 | 1.67 | 57 | Palliative (P) | 2017-03-31 | 2017-04-02 | KESTREL Trial | N | null | 300024396 | CARBOPLATIN |
| 300006896 | 300004969 | 1.59 | 54.9 | Neo-adjuvant (N) | 2016-05-18 | 2016-05-21 | DE-ESCALATE TRIAL | 01 | null | 300024396 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006897 | 300004970 | null | null | Palliative (P) | 2016-08-10 | 2016-08-23 | Gemcitabine + Capecitabine | N | N | 300024413 | OXALIPLATIN + MDG |
| 300006898 | 300004972 | 1.62 | 66.35 | Palliative (P) | 2015-06-29 | 2015-07-15 | Carboplatin AUC 6 - 10 | 02 | null | 300024423 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006899 | 300004973 | 1.77 | 58 | Palliative (P) | 2014-09-03 | 2014-10-01 | null | N | N | 300024434 | CETUXIMAB + RT |
| 300006900 | 300007065 | 1.67 | 97.7 | null | 2017-12-13 | 2017-12-13 | Capecitabine + Cisplatin | 1 | N | 300024471 | METHOTREXATE INTRATHECAL |
| 300006901 | 300007829 | 1.74 | 75.6 | Adjuvant (A) | 2014-10-07 | 2014-11-02 | Folfirinox | N | N | 300024471 | DHAP - R |
| 300006902 | 300007829 | 1.7 | 96.1 | Curative (C) | 2015-10-22 | 2015-10-22 | DE-ESCALATE TRIAL | 2 | Y | 300024471 | CAPECITABINE + RT |
| 300006903 | 300007829 | 1.63 | 59 | null | 2016-06-10 | 2016-06-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 300024471 | CARBOPLATIN |
| 300006904 | 300004974 | 1.64 | 65 | Palliative (P) | 2014-05-31 | 2014-10-04 | Carboplatin + Cetux + FU (Cycle 1) | 2 | N | 300024529 | CAPECITABINE |
| 300006905 | 300004976 | 1.75 | 89.7 | Palliative (P) | 2016-06-04 | 2016-06-10 | Docetaxel 75mg/m2 (21 day) | 02 | N | 300024538 | CISPLATIN + FLUOROURACIL |
| 300006906 | 300004976 | 1.58 | null | Palliative (P) | 2014-11-15 | 2014-12-03 | Capecitabine | 02 | N | 300024538 | TEMOZOLOMIDE |
| 300006907 | 300004977 | null | 66 | Curative (C) | 2016-12-28 | 2017-04-29 | Cetuximab + Radiotherapy Load | N | Y | 300024567 | CISPLATIN |
| 300006908 | 300004977 | 1.88 | 52 | Curative (C) | 2017-02-09 | 2017-02-11 | FLUOROURACIL + RT | N | Y | 300024567 | CARBOPLATIN + RT |
| 300006909 | 300004978 | 1.8 | 66 | Curative (C) | 2016-09-30 | 2016-10-29 | CAPECITABINE + CARBOPLATIN + Cetuximab | 2 | N | 300024586 | PACLITAXEL |
| 300006910 | 300007069 | 1.84 | 75.5 | Palliative (P) | null | 2017-01-17 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 300024597 | CAPECITABINE + GEMCITABINE |
| 300006911 | 300004979 | 1.6 | 48 | Palliative (P) | 2014-09-02 | 2014-09-07 | CETUXIMAB | N | null | 300024603 | HYDROXYCARBAMIDE |
| 300006912 | 300004980 | 1.74 | 62.9 | Adjuvant (A) | 2013-07-31 | 2013-08-14 | Capecitabine | N | N | 300024619 | BENDAMUSTINE + RITUXIMAB |
| 300006913 | 300004981 | 1.81 | null | Disease modification (D) | 2017-06-03 | 2017-08-23 | Oxaliplatin + Modified de Gramont | N | N | 300024623 | OXALIPLATIN + MDG |
| 300006914 | 300007070 | null | 69.85 | Palliative (P) | 2014-04-26 | 2014-05-23 | Folfirinox | 02 | N | 300024630 | CAPECITABINE + OXALIPLATIN |
| 300006915 | 300004982 | 1.57 | 72.65 | Palliative (P) | 2014-12-09 | 2014-12-10 | CARBOPLATIN + FLUOROURACIL | 02 | N | 300024682 | CAPECITABINE |
| 300006916 | 300007071 | 1.55 | 79 | Palliative (P) | 2015-05-08 | 2015-10-02 | Temozolomide 200mg/m2 | N | N | 300024691 | CISPLATIN + FLUOROURACIL |
| 300006917 | 300007071 | null | 59.8 | Palliative (P) | 2014-11-20 | 2014-11-26 | Cetuximab 7 day (>Cycle 2) | N | N | 300024691 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006918 | 300007071 | 1.66 | 44.4 | Palliative (P) | 2018-05-06 | 2018-05-06 | CARBOPLATIN + RT | 02 | Y | 300024691 | CETUXIMAB |
| 300006919 | 300004983 | 1.71 | 71.4 | Palliative (P) | 2014-12-01 | 2014-12-06 | FLUOROURACIL | N | N | 300024724 | TRIAL |
| 300006920 | 300004984 | 1.75 | null | Adjuvant (A) | 2015-08-20 | 2015-11-08 | ESPAC-4 TRIAL | N | null | 300024735 | CARBOPLATIN + PACLITAXEL |
| 300006921 | 300004986 | 1.63 | 83.9 | Palliative (P) | 2014-09-12 | 2014-10-08 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | 300024757 | DABRAFENIB + TRAMETINIB |
| 300006923 | 300007073 | 1.6 | 55 | Curative (C) | 2017-03-06 | 2017-03-06 | CISPLATIN + FLUOROURACIL | 2 | Y | 300024775 | NIVOLUMAB |
| 300006924 | 300007073 | 1.59 | 61.8 | Curative (C) | null | 2013-07-07 | Oxaliplatin + Modified de Gramont | N | Y | 300024775 | CISPLATIN |
| 300006925 | 300004988 | null | 82 | Palliative (P) | 2013-07-23 | 2014-08-06 | CARBOPLATIN + Cetuximab + FLUOROURACIL | Y | N | 300024784 | TRIAL |
| 300006926 | 300004989 | 1.7 | 51.5 | Neo-adjuvant (N) | 2017-09-19 | 2017-10-01 | CISPLATIN + FLUOROURACIL | 02 | null | 300024788 | CETUXIMAB + IRINOTECAN + MDG |
| 300006927 | 300007074 | 1.7 | 72.4 | Palliative (P) | 2015-09-18 | 2015-09-23 | Capecitabine (21days) + Carboplatin | N | N | 300024790 | GEMCARBO |
| 300006928 | 300004992 | 1.55 | 66.5 | Curative (C) | 2013-07-22 | 2013-08-06 | Carboplatin + Cetux + FU (>Cycle 2) | 2 | Y | 300024793 | CETUXIMAB + RT |
| 300006929 | 300004994 | 1.59 | null | Palliative (P) | 2016-01-31 | 2016-02-05 | ESHAP R | Y | N | 300024807 | PACLITAXEL |
| 300006930 | 300004995 | 1.73 | 93.5 | Disease modification (D) | 2015-08-25 | 2015-09-25 | Nelarabine | N | N | 300024838 | CAPECITABINE + OXALIPLATIN |
| 300006931 | 300004997 | 1.74 | null | Adjuvant (A) | 2015-01-06 | 2015-01-06 | Rituximab | 02 | N | 300024840 | CARBOPLATIN + ETOPOSIDE |
| 300006932 | 300007076 | 1.52 | 58.6 | Palliative (P) | 2015-06-21 | 2015-06-23 | MITOTANE | 02 | N | 300024858 | CARBOPLATIN + CETUXIMAB + FU |
| 300006933 | 300004999 | 1.78 | 90.7 | Palliative (P) | 2015-03-14 | 2015-03-19 | Carboplatin AUC 6 - 10 | N | null | 300024875 | DE-ESCALATE TRIAL |
| 300006936 | 300005003 | null | null | Disease modification (D) | 2016-06-21 | 2016-07-16 | Capecitabine | N | N | 300024887 | IRINOTECAN + MDG |
| 300006937 | 300007079 | null | 65.4 | Curative (C) | 2015-10-26 | 2015-11-29 | Capecitabine + Oxaliplatin 21day | N | N | 300024904 | TRIAL |
| 300006938 | 300007079 | 1.73 | 66.3 | Adjuvant (A) | 2017-09-27 | 2017-10-02 | CARBOPLATIN + FLUOROURACIL | N | N | 300024904 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |